Valeant Pharmaceuticals International Inc. (NYSE:VRX) is yet another healthcare stock owned by both Halvorsen and Lykouretzos. It seems that they are working in tandem like two legs walking, as they both reduced their positions in Valeant. In its most recent 13F filing, Viking Global disclosed ownership of 4.06 million shares valued at $806.07 million, whereas Hoplite Capital Management reported owning a lesser stake of 962,721 shares worth $191.22 million. The shares of Valeant have grown by over 59% since the beginning of the current year and there are no major signs that the stock will stop rising. Even though Valeant have been previously criticized for its growth plan driven by acquisitions, it keeps seeking out potential purchases. Just recently, Valeant approached Zoetis, an animal health company, with an acquisition offer. Within our database, Bill Ackman’s Pershing Square represents the largest investor in Valeant Pharmaceuticals International Inc. (NYSE:VRX), holding a stake of 19.47 million shares.
Follow John Lykouretzos's Hoplite Capital Management
Oddly, Andreas Halvorsen and John Lykouretzos have made different moves in Sealed Air Corporation (NYSE:SEE). Viking Capital augmented its position in the company by 11.24 million shares to 14.48 million shares, which are valued at $659.49 million as of March 31. Meanwhile, Hoplite Capital Management reported the sell-off of 1.14 million shares, ending the first quarter with 5.04 million shares valued at $229.67 million. The stock has increased by almost 24% year-to-date and is now trading at $52 per share. Sealed Air, which is a global manufacturer of protective and specialty packaging for food and consumer goods, is expected to increase the share of revenues from its new products to 20% by 2020, compared to the current figure of 13%. Moreover, analysts believe that the company will outperform the market by creating and targeting new markets with its value sell business model. David E. Shaw’s D.E. Shaw & Co. is among the largest shareholders in Sealed Air Corporation (NYSE:SEE), with 3.11 million shares.
Lastly, the two Tiger Cubs both took long positions in Envision Healthcare Holdings Inc. (EVHC) during the most recent quarter. Viking Capital reported owning a stake of 6.85 million shares in Envision, which are valued at $262.76 million. Simultaneously, Hoplite Capital Management disclosed in its 13F filing that it owns 2.62 million shares in the company valued at $100.36 million. The shares of Envision have grown by over 15% year-to-date, trading at around $40 per share. The financial performance of the company for the first quarter of the year was at least in line with the analysts’ expectations. Envision reported a profit per share of $0.17 and earnings, adjusted for amortization costs and costs related to M&A activities, of $0.26 per share, which met the Wall Street forecasts. Moreover, the company delivered better-than-expected revenue of $1.24 billion for the period. Within our database of over 700 hedge funds, Daniel S. Och’s OZ Management is the largest investor in Envision Healthcare Holdings Inc. (EVHC), owning 8.24 million shares.
Disclosure: None
